Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

Medical Consumables Market Rapid Growth at 12.05% CAGR Propelled by Rising Chronic Diseases, Infection Control Standards, and Technological ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

I don't think we've ever written about Intravenous 2, but the topdown shooter has been on my radar since its release last ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...

A prediction for 2025 by Marci Chodroff, M.D., vice president of Medical Affairs at Prime Therapeutics and Managed Healthcare ...

NDAQ:CRBU) Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 ...

Anemia during pregnancy is a global health challenge, affecting 37% of expectant mothers worldwide. In sub-Saharan Africa, ...

Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...

Want to prevent iron deficiency during pregnancy? Iron plays a key role in preventing anemia and promoting overall wellness for both the mother and child.

1 Department of Pharmacy, Tianjin First Central Hospital, Nankai University, Tianjin, China 2 College of Chemistry, Nankai University, Tianjin, China The administered infusion solution is a sterile ...